1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kobayashi, K.
Sasaki, T.
Sato, K.
Kohno, T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
39
14761
14767
10.1021/bi001506x
11101291
Three-dimensional solution structure of omega-conotoxin TxVII, an L-type calcium channel blocker.
2000
10.2210/pdb1f3k/pdb
pdb_00001f3k
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2841.350
OMEGA-CONOTOXIN TXVII
1
syn
polymer
no
no
CKQADEPCDVFSLDCCTGICLGVCMW
CKQADEPCDVFSLDCCTGICLGVCMW
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2000-12-13
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
RCSB
Y
RCSB
2000-06-05
REL
This peptide was chemically synthesized. The sequence of this peptide naturally occurs in Conus textile.
sample
This structure was determined using standard 2D homonuclear techniques.
structures with the lowest energy
100
20
2D NOESY
DQF-COSY
TOCSY
2D NOESY
DQF-COSY
PE-COSY
0
5.6
ambient
288
K
The structures are based on a total of 452 restraints, 411 are NOE-derived
distance constraints, 20 dihedral angle restraints, 21 distance restraints
from hydrogen bonds and disulfide bonds.
distance geometry, simulated annealing
5mM omega-conotoxin TxVII
90% H2O/10% D2O
5mM omega-conotoxin TxVII
D2O
Bruker
collection
UXNMR
970101.2
Bruker
processing
UXNMR
970101.2
Bruker
data analysis
UXNMR
970101.2
Brunger
data analysis
X-PLOR
3.1
Brunger
refinement
X-PLOR
3.1
Brunger
structure solution
X-PLOR
3.1
500
Bruker
AMX
CYS
1
n
1
CYS
1
A
LYS
2
n
2
LYS
2
A
GLN
3
n
3
GLN
3
A
ALA
4
n
4
ALA
4
A
ASP
5
n
5
ASP
5
A
GLU
6
n
6
GLU
6
A
PRO
7
n
7
PRO
7
A
CYS
8
n
8
CYS
8
A
ASP
9
n
9
ASP
9
A
VAL
10
n
10
VAL
10
A
PHE
11
n
11
PHE
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
ASP
14
n
14
ASP
14
A
CYS
15
n
15
CYS
15
A
CYS
16
n
16
CYS
16
A
THR
17
n
17
THR
17
A
GLY
18
n
18
GLY
18
A
ILE
19
n
19
ILE
19
A
CYS
20
n
20
CYS
20
A
LEU
21
n
21
LEU
21
A
GLY
22
n
22
GLY
22
A
VAL
23
n
23
VAL
23
A
CYS
24
n
24
CYS
24
A
MET
25
n
25
MET
25
A
TRP
26
n
26
TRP
26
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ALA
4
-36.86
133.83
1
A
ASP
5
82.04
18.38
1
A
PHE
11
-141.18
-36.96
1
A
SER
12
-135.64
-74.57
1
A
ASP
14
-162.60
-86.52
1
A
CYS
16
-57.71
-2.40
1
A
ILE
19
-127.55
-150.82
1
A
MET
25
-95.05
38.33
2
A
ALA
4
-39.02
127.80
2
A
ASP
5
88.49
17.91
2
A
PHE
11
-130.45
-38.32
2
A
SER
12
-160.81
-80.75
2
A
ASP
14
-160.18
-3.50
2
A
CYS
15
178.14
106.33
2
A
CYS
16
-59.22
-3.09
2
A
ILE
19
-111.32
-143.50
2
A
CYS
20
-159.81
70.94
2
A
CYS
24
-56.73
90.27
3
A
ALA
4
-37.94
116.64
3
A
ASP
5
92.24
20.83
3
A
PHE
11
-136.46
-42.44
3
A
SER
12
-160.61
-76.16
3
A
ASP
14
-160.70
-17.90
3
A
CYS
15
-172.50
119.23
3
A
ILE
19
-107.38
-147.57
3
A
CYS
24
-41.11
95.84
3
A
MET
25
-79.49
-165.20
4
A
ALA
4
-37.01
120.78
4
A
ASP
5
86.94
30.59
4
A
SER
12
-160.05
-54.07
4
A
ASP
14
-161.94
-88.40
4
A
THR
17
-143.27
14.22
4
A
CYS
20
-116.65
65.36
5
A
ALA
4
-37.56
128.00
5
A
ASP
5
83.30
19.53
5
A
PHE
11
-144.50
-27.05
5
A
SER
12
-161.55
-86.15
5
A
ASP
14
-161.84
-25.03
5
A
CYS
16
-43.99
-17.44
5
A
ILE
19
-95.63
-154.60
5
A
LEU
21
-90.83
59.81
5
A
CYS
24
-39.34
107.90
5
A
MET
25
-77.71
-164.08
6
A
ALA
4
-38.31
136.88
6
A
ASP
5
80.91
10.22
6
A
PHE
11
-134.49
-35.07
6
A
SER
12
-161.05
-80.88
6
A
ASP
14
-160.63
10.62
6
A
CYS
15
175.13
106.96
6
A
ILE
19
-114.18
-149.35
6
A
CYS
20
-158.74
78.20
6
A
LEU
21
-89.22
47.45
6
A
CYS
24
-61.05
99.62
6
A
MET
25
-94.33
53.52
7
A
ALA
4
-37.84
128.47
7
A
ASP
5
87.81
19.15
7
A
PHE
11
-131.23
-37.36
7
A
SER
12
-160.81
-79.03
7
A
ASP
14
-159.98
-12.64
7
A
CYS
15
-173.19
111.98
7
A
CYS
24
-41.15
98.63
7
A
MET
25
-76.15
-153.61
8
A
ALA
4
-38.25
127.85
8
A
ASP
5
83.44
19.61
8
A
PHE
11
-149.16
-35.17
8
A
SER
12
-132.32
-86.79
8
A
ASP
14
-162.03
-21.40
8
A
CYS
16
-48.93
-19.08
9
A
ALA
4
-37.94
137.87
9
A
ASP
5
87.76
4.84
9
A
SER
12
-161.05
-83.49
9
A
ASP
14
-164.24
-38.48
9
A
CYS
16
-56.15
-8.83
9
A
ILE
19
-135.07
-152.06
9
A
LEU
21
-90.81
52.52
9
A
CYS
24
-52.14
94.57
10
A
ALA
4
-38.52
139.43
10
A
ASP
5
84.21
4.97
10
A
PHE
11
-132.60
-38.36
10
A
SER
12
-160.36
-73.25
10
A
ASP
14
-160.78
-18.77
10
A
CYS
15
-173.03
114.53
10
A
CYS
16
-57.70
-6.82
10
A
ILE
19
-114.68
-150.60
10
A
MET
25
-95.36
50.58
11
A
ALA
4
-38.74
121.57
11
A
ASP
5
89.20
23.25
11
A
PHE
11
-141.57
-34.66
11
A
SER
12
-159.83
-80.77
11
A
ASP
14
-161.11
-23.61
11
A
CYS
15
-164.21
117.16
11
A
ILE
19
-103.39
-156.05
11
A
CYS
24
-43.49
95.10
11
A
MET
25
-78.05
-161.76
12
A
ALA
4
-37.99
120.49
12
A
ASP
5
92.01
19.62
12
A
PHE
11
-133.78
-41.47
12
A
SER
12
-160.61
-76.58
12
A
ASP
14
-161.04
-24.08
12
A
CYS
15
-161.28
109.79
12
A
ILE
19
-105.64
-149.41
12
A
LEU
21
-86.89
48.57
12
A
CYS
24
-41.54
94.65
12
A
MET
25
-78.42
-164.80
13
A
ALA
4
-38.75
128.04
13
A
ASP
5
83.76
15.20
13
A
PHE
11
-140.19
-24.92
13
A
SER
12
-161.00
-87.83
13
A
CYS
15
-176.69
106.64
13
A
ILE
19
-124.59
-152.71
13
A
CYS
20
-157.70
88.39
13
A
CYS
24
-63.94
94.63
14
A
ALA
4
-37.09
121.48
14
A
ASP
5
85.59
26.50
14
A
PHE
11
-146.60
-36.06
14
A
SER
12
-136.18
-82.94
14
A
ASP
14
-161.99
-85.13
14
A
CYS
24
-39.83
104.82
14
A
MET
25
-78.20
-162.46
15
A
ALA
4
-36.54
119.46
15
A
ASP
5
88.15
27.26
15
A
VAL
10
-90.45
58.64
15
A
PHE
11
-147.76
-34.08
15
A
SER
12
-130.62
-76.81
15
A
ASP
14
-161.60
-85.51
15
A
CYS
16
-49.24
-12.75
15
A
THR
17
-145.83
40.74
15
A
MET
25
-78.31
-169.09
16
A
ALA
4
-37.63
119.94
16
A
ASP
5
90.87
23.84
16
A
VAL
10
-90.53
57.39
16
A
PHE
11
-158.10
-28.48
16
A
SER
12
-137.96
-83.48
16
A
ASP
14
-164.27
-86.65
16
A
ILE
19
-102.21
-149.96
16
A
CYS
20
-153.83
81.22
16
A
LEU
21
-89.85
43.74
16
A
CYS
24
-45.61
100.26
16
A
MET
25
-78.01
-162.97
17
A
ALA
4
-39.13
134.88
17
A
ASP
5
84.77
4.77
17
A
CYS
8
-160.81
-168.92
17
A
PHE
11
-139.00
-40.06
17
A
SER
12
-130.89
-77.37
17
A
ASP
14
-161.84
-34.03
17
A
LEU
21
-88.35
48.07
17
A
CYS
24
-39.79
108.18
18
A
ALA
4
-36.23
129.35
18
A
SER
12
-160.16
-73.17
18
A
ASP
14
-161.96
-85.41
18
A
CYS
16
-47.60
-14.56
18
A
ILE
19
-110.37
-166.15
18
A
MET
25
-76.50
-163.29
19
A
ALA
4
-38.93
143.15
19
A
PHE
11
-160.69
-32.42
19
A
SER
12
-139.00
-86.32
19
A
ASP
14
-164.24
-62.27
19
A
CYS
16
-44.53
-19.89
19
A
LEU
21
-92.19
45.20
20
A
ALA
4
-39.28
140.12
20
A
ASP
5
81.65
5.30
20
A
PHE
11
-143.84
-37.47
20
A
SER
12
-127.90
-75.35
20
A
ASP
14
-161.85
-84.83
20
A
CYS
16
-38.76
-25.57
20
A
CYS
20
-117.44
59.72
20
A
LEU
21
-88.71
49.60
THREE-DIMENSIONAL SOLUTION STRUCTURE OF OMEGA-CONOTOXIN TXVII, AN L-TYPE CALCIUM CHANNEL BLOCKER
1
N
N
disulf
2.018
A
CYS
1
A
SG
CYS
1
1_555
A
CYS
16
A
SG
CYS
16
1_555
disulf
2.019
A
CYS
8
A
SG
CYS
8
1_555
A
CYS
20
A
SG
CYS
20
1_555
disulf
2.015
A
CYS
15
A
SG
CYS
15
1_555
A
CYS
24
A
SG
CYS
24
1_555
TOXIN
OMEGA-CONOTOXIN, CYSTINE KNOT MOTIF, TRIPLE-STRANDED ANTIPARALLEL BETA-SHEET, L-TYPE CALCIUM CHANNEL BLOCKER, TOXIN
CXO7_CONTE
UNP
1
1
P56714
CKQADEPCDVFSLDCCTGICLGVCMW
1
26
1F3K
1
26
P56714
A
1
1
26
1
P 1